Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release
Abdul Hakeem,1,2,* Fouzia Zahid,1,* Guiting Zhan,1 Ping Yi,3 Hai Yang,1 Lu Gan,1 Xiangliang Yang1 1National Engineering Research Center for Nanomedicine, Department of Nanomedicine and Biopharmaceuticals, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan,...
Guardado en:
Autores principales: | Hakeem A, Zahid F, Zhan G, Yi P, Yang H, Gan L, Yang X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c03b9a1b5c894e83b2130cdf6684ebfe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Redox/pH dual-controlled release of chlorhexidine and silver ions from biodegradable mesoporous silica nanoparticles against oral biofilms
por: Lu MM, et al.
Publicado: (2018) -
pH DEPENDENT DRUG DELIVERY BASED ON SILICA XEROGEL
por: VASCONCELOS,AÉCIO B. P. DE, et al.
Publicado: (2017) -
A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells
por: Shen Y, et al.
Publicado: (2019) -
Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release
por: Shahein SA, et al.
Publicado: (2019) -
Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
por: Zhuang J, et al.
Publicado: (2021)